A programming algorithm is being tested by HonorHealth Research Institute for patients with new or recently installed pacemakers, designed so the device not only provides a steady heartbeat but also controls high blood pressure.
You must be a member to read this story.
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Current print subscribers can create a free account by clicking here
Otherwise, follow the link below to join.
To Our Valued Readers –
Visitors to our website will be limited to five stories per month unless they opt to subscribe. The five stories do not include our exclusive content written by our journalists.
For $6.99, less than 20 cents a day, digital subscribers will receive unlimited access to YourValley.net, including exclusive content from our newsroom and access to our Daily Independent e-edition.
Our commitment to balanced, fair reporting and local coverage provides insight and perspective not found anywhere else.
Your financial commitment will help to preserve the kind of honest journalism produced by our reporters and editors. We trust you agree that independent journalism is an essential component of our democracy. Please click here to subscribe.
Need to set up your free e-Newspaper all-access account? click here.
Non-subscribers
Click here to see your options for becoming a subscriber.
Register to comment
Click here create a free account for posting comments.
Note that free accounts do not include access to premium content on this site.
I am anchor
Research
HonorHealth tests new algorithm for pacemakers
Metro Creative Connection
HonorHealth Research Institute is exploring a new programming algorithm for patients with pacemakers.
Posted
A programming algorithm is being tested by HonorHealth Research Institute for patients with new or recently installed pacemakers, designed so the device not only provides a steady heartbeat but also controls high blood pressure.
A recently opened clinical trial called BACKBEAT (BradycArdia paCemaKer for Blood prEssure treAtmenT) aims to use Medtronic’s Astra and Azure model pacemakers to not only treat slow heart rates but also delivers electrical pulses stimulating the heart in a way that reduces the patient’s blood pressure, a press release explained.
The clinical trial is for patients who require a pacemaker, but who no longer respond well to their current high blood pressure medication.
“It’s a huge, huge health problem,” Dr. Rahul Doshi, an electrophysiologist in the Research Institute’s Cardiovascular Research Division, stated in the release. “Many patients who require a pacemaker have uncontrolled high blood pressure”.
The electrical system of the heart works by coordinating the function of the upper chambers and the lower chambers in order to function as a pump delivering blood to the whole body, the release detailed.
By varying the timing of heartbeats for the upper and lower chambers, the new algorithm can lower blood pressure by several mechanisms and have a lasting benefit. Reducing high blood pressure lowers the risk of life-threatening strokes, heart attacks and cardiovascular diseases.
“This therapy works automatically without the patient or the doctor having to do anything. You just turn it on, and it works,” Dr. Doshi stated. “It’s very promising. It’s been demonstrated in all of our preliminary data that, not only does this work, but it also has a lasting benefit if you continue the therapy.”
Previous attempts to cultivate a non-drug method of controlling high blood pressure did not provide a lasting effect, according to Doshi.
For information about HonorHealth Research Institute cardiovascular clinical trials, contact heartclinicaltrials@honorhealth.com or 480-323-1046.
